Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Efficacy of the treatment with a COX-2 specific inhibitor celecoxib in osteoarthritic patients
ISRCTN ISRCTN55717501
ClinicalTrials.gov identifier
Public title Efficacy of the treatment with a COX-2 specific inhibitor celecoxib in osteoarthritic patients
Scientific title
Acronym COXOA
Serial number at source N/A
Study hypothesis Our hypothesis is that celecoxib could have a specific antiinflammatory profile to that of a classic antiinflammatory treatment on patients with knee osteoarthritis (OA).
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment Spain
Disease/condition/study domain Advanced osteoarthritis
Participants - inclusion criteria Patients with clinical and radiological evidence of knee OA who met the American Rheumatism Association criteria for functional classes III or IV, who were scheduled for total knee replacement and who accepted to be treated with an antiinflammatory drug.
Participants - exclusion criteria Pregnancy, gastrointestinal pathology, kidney or hepatic insufficiency, diabetes, cardiovascular disease, oncologic patients.
Anticipated start date 12/02/2002
Anticipated end date 12/02/2003
Status of trial Completed
Patient information material
Target number of participants 30
Interventions Comparison of celecoxib treatment versus aceclofenac treatment
Primary outcome measure(s) Synovial inflammation markers on the synovial membrane of osteoarthritis patients
Secondary outcome measure(s) Effect on Western Ontario McMaster Universities Osteoarthritis (WOMAC) index
Sources of funding Mapfre Medicina Foundation (grant 2003), Spanish Ministery of Education (SAF 08/0379), Fondo de Investigaciones Sanitarias (CP03/00011), Pfizer Spain
Trial website
Publications 2008 results on http://www.ncbi.nlm.nih.gov/pubmed/18547825
Contact name Dr  Javier  Santillana
  Address Orthopaedic Department
Hospital de Tortosa Virgen de la Cinta
Esplanetes 47
  City/town Tortosa - Tarragona
  Zip/Postcode 43500
  Country Spain
  Tel +34 977519133
  Fax +34 977519200
  Email jsanmher@eresmas.com
Sponsor Hospital de Tortosa Virgen de la Cinta (Spain)
  Address Javier Santillana
Orthopaedic Department
Hospital de Tortosa Virgen de la Cinta
Esplanetes 47
  City/town Tortosa - Tarragona
  Zip/Postcode 43500
  Country Spain
  Tel +34 977519133
  Fax +34 977519200
  Email jsanmher@eresmas.com
Date applied 06/07/2005
Last edited 02/10/2008
Date ISRCTN assigned 08/07/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central